Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac: interim guidance, 24 May 2021
31 May 2021
| Report
Editors
World Health Organization. Regional Office for Europe
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/Sinovac-CoronaVac/2021.1